ATE207967T1 - Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen - Google Patents

Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen

Info

Publication number
ATE207967T1
ATE207967T1 AT95921264T AT95921264T ATE207967T1 AT E207967 T1 ATE207967 T1 AT E207967T1 AT 95921264 T AT95921264 T AT 95921264T AT 95921264 T AT95921264 T AT 95921264T AT E207967 T1 ATE207967 T1 AT E207967T1
Authority
AT
Austria
Prior art keywords
crohn
disease
screening
microsatellite alleles
nucleic acid
Prior art date
Application number
AT95921264T
Other languages
English (en)
Inventor
Scott E Plevy
Jerome I Rotter
Stephan R Targan
Hiroo Toyoda
Huiying Yang
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of ATE207967T1 publication Critical patent/ATE207967T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95921264T 1994-05-17 1995-05-17 Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen ATE207967T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24529794A 1994-05-17 1994-05-17
PCT/US1995/006107 WO1995031575A1 (en) 1994-05-17 1995-05-17 Methods of screening for crohn's disease using tnf microsatellite alleles

Publications (1)

Publication Number Publication Date
ATE207967T1 true ATE207967T1 (de) 2001-11-15

Family

ID=22926104

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921264T ATE207967T1 (de) 1994-05-17 1995-05-17 Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen

Country Status (9)

Country Link
US (2) US6001569A (de)
EP (1) EP0760010B1 (de)
AT (1) ATE207967T1 (de)
AU (1) AU698604B2 (de)
CA (1) CA2190586A1 (de)
DE (1) DE69523586T2 (de)
DK (1) DK0760010T3 (de)
ES (1) ES2166822T3 (de)
WO (1) WO1995031575A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300060B1 (en) 1995-11-09 2001-10-09 Dana-Farber Cancer Institute, Inc. Method for predicting the risk of prostate cancer morbidity and mortality
AU2456197A (en) * 1996-04-12 1997-11-07 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease
WO1997039146A1 (en) * 1996-04-12 1997-10-23 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease
US5968741A (en) * 1997-04-11 1999-10-19 Cedars-Sinai Medical Center Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
US6183951B1 (en) 1997-04-11 2001-02-06 Prometheus Laboratories, Inc. Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy
US20030148288A1 (en) * 2002-02-01 2003-08-07 Yi-Wei Tang Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
US6881983B2 (en) * 2002-02-25 2005-04-19 Kopin Corporation Efficient light emitting diodes and lasers
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
US20070041905A1 (en) * 2005-08-19 2007-02-22 Hoffman Rebecca S Method of treating depression using a TNF-alpha antibody
US8486640B2 (en) 2007-03-21 2013-07-16 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
GB201223223D0 (en) 2012-12-21 2013-02-06 Norinnova Technology Transfer As Inflammatory bowel disease
KR20240122922A (ko) 2013-03-27 2024-08-13 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
EP4105236A1 (de) 2013-07-19 2022-12-21 Cedars-Sinai Medical Center Anti-tl1a (tnfsf15) antikörper zur behandlung von entzündlichen darmerkrankungen
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
CN111670254B (zh) * 2018-02-20 2024-10-11 豪夫迈·罗氏有限公司 微卫星不稳定性的改进检测
CN112831558B (zh) * 2021-03-10 2022-12-20 北京科力丹迪生物医疗科技有限公司 克罗恩病易感基因的早筛方法及试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007485A1 (en) * 1991-10-10 1993-04-15 The Regents Of The University Of California Rare immunoglobulin framework regions associated with human disease
US5225329A (en) * 1991-10-18 1993-07-06 Yale University Method for early detection of intestinal ischemia

Also Published As

Publication number Publication date
US6534263B1 (en) 2003-03-18
EP0760010B1 (de) 2001-10-31
US6001569A (en) 1999-12-14
ES2166822T3 (es) 2002-05-01
WO1995031575A1 (en) 1995-11-23
CA2190586A1 (en) 1995-11-23
EP0760010A1 (de) 1997-03-05
AU2638495A (en) 1995-12-05
DE69523586T2 (de) 2002-07-18
DK0760010T3 (da) 2002-02-25
AU698604B2 (en) 1998-11-05
DE69523586D1 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
ATE207967T1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
DE3481775D1 (de) Verfahren zum raschen nachweis von mikroorganismen in klinischen proben.
ATE250671T1 (de) Verfahren mit einer hohen umsatzrate für das auffinden von sequenzen oder genetischen veränderungen in nukleinsäuren
DE3778355D1 (de) Verfahren zur entkeimung von mit lebenden zellen umgebenen oberflaechen.
DE69535802D1 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
WO2000037679A3 (en) Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis
DE3576811D1 (de) Verfahren zur herstellung von ein eisencarbid enthaltenden nadelfoermigen teilchen.
DE3682149D1 (de) Verfahren zur quantitativen bestimmung von 1,5-anhydroglucitol.
DE69718054D1 (de) Verfahren zur aufreinigung von dns
FI946127A7 (fi) Menetelmä alukkeen pidentämiseksi yhdellä nukleotidilla spesifisten al leelien detektoimiseksi, ja testipakkaus näiden menetelmien suorittami seksi
DE69737812D1 (de) Diagnose durch Bestimmung von Polymorphismen in der Promoterregion des TGF-Beta 1 Gens
DE3483252D1 (de) Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
ATE335844T1 (de) Verfahren zur bestimmung des kardiovasculären status und zusammensetzungen zu deren verwendung
ATE126830T1 (de) Verfahren zum nachweis von kleinzelligem carzinom und die verwendung von sequenzen, die acylpeptid- hydrolase codieren, für diesen zweck.
DE69704328D1 (de) Verfahren zur quantitativen Bestimmung von 1,5-Anhydroglucitol, sowie Reagenz zur quantitativen Bestimmung
DE69927846D1 (de) Verfahren für die feststellung von asthma suszeptibilität
DE59203628D1 (de) Verfahren zur Verbesserung der Lichtechtheit von Leder.
DE69018500D1 (de) Verfahren zur Schmelzreduktion von Nickelerzen.
EP0398709A3 (de) Genetische Diagnose von Torsion-Dystonia
DE58904756D1 (de) Verfahren zur herstellung von tert.-amylalkohol (taa).
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
DE3674074D1 (de) Verfahren zur festigkeitsverbesserung durch waermebehandlung.
DE3483624D1 (de) Verfahren zur herstellung von kornorientiertem siliziumstahl.
DE3880654D1 (de) Verfahren zur herstellung von kornorientierten siliciumstahlblechen mit niedrigen wattverlusten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee